LPL Financial
VRCA icon

LPL Financial’s Verrica Pharmaceuticals VRCA Stock Holding History

LPL Financial’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,414
Closed -$250K – 5035
2023
Q4 		$250K Sell
3,414
-199
-6% -$8.18K ﹤0.01% 4230
2023
Q3 		$140K Buy
3,613
+100
+3% +$5.08K ﹤0.01% 4348
2023
Q2 		$203K Hold
3,513
– – ﹤0.01% 4144
2023
Q1 		$228K Buy
3,513
+913
+35% +$55.2K ﹤0.01% 3943
2022
Q4 		$71.5K Buy
2,600
+400
+18% +$10.7K ﹤0.01% 4223
2022
Q3 		$64K Buy
+2,200
New +$75.4K ﹤0.01% 4198

Other funds holding VRCA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

LPL Financial's VRCA Position: Q1 2024 in Review

LPL Financial sold out of Verrica Pharmaceuticals (VRCA) in Q1 2024, closing a stake of 3,414 shares — an estimated $250K sold.

LPL Financial first reported a position in VRCA in Q3 2022 and held it in 6 quarters. The position peaked at $250K in Q4 2023. 60 funds tracked by Wall St. Rank hold VRCA as of Q1 2024.

  • LPL Financial reported no remaining Verrica Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • LPL Financial sold 3,414 Verrica Pharmaceuticals shares in Q1 2024, an estimated $250K.
  • LPL Financial first reported a position in Verrica Pharmaceuticals in Q3 2022 and held it in 6 quarters.
  • LPL Financial's Verrica Pharmaceuticals position peaked at $250K in Q4 2023.
  • 60 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q1 2024.

Based on LPL Financial's 13F filing for Q1 2024, filed 10 May 2024.